<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Genetic mutations associated with mitochondrial myopathies</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Genetic mutations associated with mitochondrial myopathies</h1>
<div class="graphic"><div class="figure"><div class="ttl">Genetic mutations associated with mitochondrial myopathies</div><div class="cntnt"><table cellspacing="0"><tbody> <tr> <td class="subtitle1_single">Mitochondrial DNA mutations</td> </tr> <tr> <td class="subtitle2_single">Mutations in genes encoding respiratory chain proteins</td> </tr> <tr> <td class="indent1">Complex I (ND1 and ND4 cause a pure myopathy; ND5 causes a myopathy with MELAS/LHON/MERRF)</td> </tr> <tr> <td class="indent1">Complex III (Cytochrome b causes exercise intolerance/myalgia and rarely causes cardiomyopathy or multisystem disorder)</td> </tr> <tr> <td class="indent1">Complex IV (COX I, COXII, COXIII) causes exercise intolerance/myoglobinuria, but can also cause severe encephalomyopathy (all three), or MELAS (COX III only)</td> </tr> <tr> <td class="subtitle2_single">Mutations affecting protein synthesis</td> </tr> <tr> <td class="indent1">Mutations in transfer RNA most commonly cause MELAS or MERRF, and can also cause isolated myopathy, CPEO, or respiratory muscle weakness</td> </tr> <tr> <td class="indent1">Mutations in ribosomal RNA cause aminoglycoside-related deafness and cardiomyopathy but not skeletal myopathy</td> </tr> <tr> <td class="indent1">Large scale deletions/duplications most often cause sporadic CPEO/Kearns-Sayre syndrome and less commonly cause Pearson syndrome</td> </tr> <tr> <td class="subtitle1_single">Nuclear DNA mutations</td> </tr> <tr> <td class="subtitle2_single">Mutations in genes encoding respiratory chain proteins</td> </tr> <tr> <td class="indent1">Coenzyme Q10 deficiency can cause isolated myopathy or rapidly fatal encephalomyopathy of infancy with nephrotic syndrome</td> </tr> <tr> <td class="indent1">Complex I mutations (NDUFS1, 2, 3, 4, 6, 7, 8, NDUFV1, 2, NDUFA1, 2, 11) and complex II mutations (SDHA) can cause autosomal recessive Leigh syndrome</td> </tr> <tr> <td class="indent1">Complex II mutations (SDHB, SDHC, SDHD) can cause paraganglioma and sarcoma</td> </tr> <tr> <td class="indent1">Complex III mutations (UQCRB, UQCRQ) can cause lactic acidosis, hypoglycemia, and psychomotor retardation</td> </tr> <tr> <td class="indent1">Complex IV mutations (COX6B1, COX4I2) can cause infantile encephalopathy, anemia, and pancreatic dysfunction</td> </tr> <tr> <td class="subtitle2_single">Mutations in nuclear genes encoding proteins required for assembly or function of the respiratory chain proteins</td> </tr> <tr> <td class="indent1">Complex I mutations (NDUFAF1, 2, 3, 4, C20orf7, C8orf38, C6orf66) can cause variable disorders including Leigh syndrome and lethal infantile encephalopathy</td> </tr> <tr> <td class="indent1">Complex II mutations (SDHAF1, 2) can cause infantile leukoencephalopathy and paraganglioma</td> </tr> <tr> <td class="indent1">Complex III mutation (BCS1L) can cause GRACILE syndrome</td> </tr> <tr> <td class="indent1">Complex IV mutations (SURF 1, COX10, COX15, SCO1, SCO2) can cause Leigh syndrome and infantile cardioencephalomyopathy</td> </tr> <tr> <td class="indent1">Complex V mutations (ATPAF2, ATP5A1, ATP5E, TMEM70) can cause encephalopathy and 3-methylglutaconic aciduria</td> </tr> <tr> <td class="subtitle2_single">Nuclear gene defects affecting mitochondrial protein synthesis (causing multiple deletions or depletion of mitochondrial DNA)</td> </tr> <tr> <td class="indent1">Mutations in POLG, C10orf2 (encodes twinkle helicase), RRM2B, SLC25A4, POLG2, and DGUOK can cause autosomal dominant or recessive CPEO</td> </tr> <tr> <td class="indent1">Mutations in TK2, SUCLA2, SUCLA2, SUCLG1, RRM2B, and DGUOK can cause congenital encephalomyopathy and muscular dystrophy-like encephalomyopathy; TK2 mutations can also cause a slowly progressive generalized myopathy</td> </tr> <tr> <td class="subtitle2_single">Nuclear gene mutations causing defects of mitochondrial dynamics (fusion/fission)</td> </tr> <tr> <td class="indent1">Mutations in OPA1 can cause bilateral optic neuropathies and may be accompanied by sensorineural hearing loss; MFN2 mutations can cause an axonal form of Charcot-Marie-Tooth disease</td> </tr> <tr> <td class="subtitle2_single">Nuclear gene defects affecting mitochondrial proteins implicated in apoptosis</td> </tr> <tr> <td class="indent1">Mutations in AIF1 can cause multiple mtDNA deletions or mtDNA depletion and present with a mitochondrial encephalomyopathy; FASTKD2 may also present with a mitochondrial encephalomyopathy; APOPT1 mutations can cause a leukodystrophy</td> </tr> <tr> <td class="subtitle2_single">Nuclear gene mutations resulting in defects of the lipid milieu</td> </tr> <tr> <td class="indent1">TAZ mutations can cause Barth syndrome, an X-linked mitochondrial myopathy, cardiomyopathy, neutropenia, and short stature</td> </tr> <tr> <td class="indent1">SERAC1 mutations can cause MEGDEL</td> </tr> <tr> <td class="subtitle2_single">Nuclear gene defects affecting mitochondrial metabolic pathways other than the respiratory chain</td> </tr> <tr> <td class="indent1">Defects of mitochondrial substrate transport include CPT 1A deficiency, which results mainly in hepatic disease; CPT 2 deficiency most commonly produces a syndrome of recurrent rhabdomyolysis</td> </tr> <tr> <td class="indent1">Defects in mitochondrial substrate utilization include trifunctional protein deficiency, which causes neuropathy, myopathy, and recurrent rhabdomyolysis</td> </tr> <tr> <td class="subtitle2_single">Nuclear gene mutations causing defects in iron-sulfur cluster assembly/homeostasis</td> </tr> <tr> <td class="indent1">Defects in ISCU are associated with myopathy, exercise intolerance, and recurrent rhabdomyolysis</td> </tr> </tbody></table></div><div class="graphic_lgnd">This table is not all-inclusive but rather lists some of the more common or more important genes associated with mitochondrial disease phenotypes in humans.</div><div class="graphic_footnotes">Barth syndrome: X-linked cardiomyopathy, mitochondrial myopathy and cyclic neutropenia; CPEO: chronic progressive external ophthalmoplegia; GRACILE syndrome: growth retardation, amino aciduria, cholestasis, iron overload, lactic acidosis and early death; Kearns-Sayre syndrome: CPEO with pigmentary retinopathy and onset before age 20; Leigh syndrome: subacute necrotizing encephalomyelopathy; LHON: Leber hereditary optic neuropathy; MEGDEL: 3-methylglutaconic aciduria with deafness, encephalopathy and Leigh-like syndrome; MELAS: mitochondrial encephalopathy with lactic acidosis and stroke-like episodes; MERRF: myoclonic epilepsy with ragged red fibers; Pearson syndrome: sideroblastic anemia and pancreatic dysfunction; RNA: ribonucleic acid; CPT: carnitine palmitoyltransferase; ISCU: iron-sulfur cluster assembly.</div><div class="graphic_reference">Data from:

<ul>
<li>DiMauro S, Hirano M. Mitochondrial encephalomyopathies: an update. Neuromuscul Disord 2005; 15:276.</li>
<li>DiMauro S. Mitochondrial myopathies. Curr Opin Rheumatol 2006; 18:636.</li>
<li>DiMauro S, Schon EA, Carelli V, Hirano M. The clinical maze of mitochondrial neurology. Nat Rev Neurol 2013; 9:429.</li>
<li>Lightowlers RN, Taylor RW, Turnbull DM. Mutations causing mitochondrial disease: What is new and what challenges remain? Science 2015; 349:1494.</li>
<li>Nardin RA, Johns DR. Mitochondrial dysfunction and neuromuscular disease. Muscle Nerve 2001; 24:170.</li>
</ul></div><div id="graphicVersion">Graphic 55067 Version 14.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
